QNTM

Quantum BioPharma Ltd. (QNTM) ESG Analysis Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Overall Score

Score: 5.0 (Moderate)

Environmental

Score:

No material environmental disclosures or sustainability metrics were provided in the fresh data.

The company remains too small and financially distressed to infer meaningful environmental progress from the available financials.

Social

Score:

No material social or workforce disclosures were provided in the fresh data.

The available metrics do not indicate a clear month-over-month change in employee, customer, or community impact.

Governance

Score:

No material governance updates or news items were provided this month.

Capital structure remains modestly levered with debt-to-equity at 0.12 and current ratio at 1.20, but profitability and cash generation remain weak.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Quantum BioPharma Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →